Status:

NOT_YET_RECRUITING

Single High-dose Brachytherapy for Giant Osteosarcoma Masses

Lead Sponsor:

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Conditions:

Osteosarcoma

Eligibility:

All Genders

12-70 years

Phase:

PHASE2

Brief Summary

This study is a prospective, single-arm, phase II, single-center study. Patients with locally unresectable giant osteosarcoma masses who meet the criteria are enrolled in the experimental group, and a...

Detailed Description

Screening period: Local MRI or CT examination, blood routine and coagulation function test. Selected treatment period: All enrolled patients received one dose of close range interstitial radiotherapy...

Eligibility Criteria

Inclusion

  • Pathological diagnosis of osteosarcoma;
  • Age range 12-70 years old;
  • The primary or metastatic lesion cannot be surgically removed based on clinical evaluation, and treatment with internal medicine multi line chemotherapy, targeted therapy, immunotherapy, etc. is ineffective;
  • ECOG physical fitness status is 0-1 points;
  • According to RECIST version 1.1 standard, there must be at least one evaluable target lesion with a mass length diameter greater than 5cm;
  • Sign a written informed consent form before conducting any experimental activities;
  • Researchers determine that they are able to comply with the research protocol;
  • Patients who are willing and able to comply with visit arrangements, treatment plans, laboratory tests, and other research procedures.

Exclusion

  • Local mass previously received radiation therapy;
  • Major surgery ≤ 4 weeks before enrollment;
  • Previous or concurrent malignant tumors (excluding malignant tumors that have been cured and have a cancer free survival of more than 5 years, such as basal cell carcinoma of the skin and papillary thyroid carcinoma);
  • Pregnant or lactating women;
  • Active pulmonary tuberculosis.

Key Trial Info

Start Date :

August 30 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2027

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT06524778

Start Date

August 30 2024

End Date

June 30 2027

Last Update

August 7 2024

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Single High-dose Brachytherapy for Giant Osteosarcoma Masses | DecenTrialz